4.7 Article

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

Jeffrey Lazarus et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects a significant portion of the global adult population, but has received little attention from the global public health community. This has led to a lack of inclusion of NAFLD in national and international strategies and policies for non-communicable diseases, highlighting the need for a more comprehensive public health response to the disease.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Medicine, Research & Experimental

Evolving Role for Pharmacotherapy in NAFLD/NASH

Suzanna L. Attia et al.

Summary: NAFLD is a prevalent and dynamic disease that can lead to serious complications, such as cirrhosis and hepatocellular carcinoma. Although there are currently no FDA-approved treatments for NAFLD, there is active research on emerging pharmacotherapies targeting various pathways within the liver. Promising phase III trials are ongoing, with obeticholic acid showing potential in reducing fibrosis in adults with NASH. Completed and ongoing clinical trials highlight the importance of understanding individualized approaches to pharmacotherapy based on NAFLD subgroups.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Review Oncology

Urinary biomarkers in bladder cancer: A review of the current landscape and future directions

Kenrick Ng et al.

Summary: This narrative review discusses established and emerging urinary biomarkers for non-muscle invasive bladder cancer, highlighting the limitations of classical FDA-approved protein biomarkers. Advancements in epigenetic and genetic markers as well as extracellular vesicles have shown promise in enhancing sensitivity and specificity in bladder cancer diagnosis. The future focus will be on utilizing these markers in combination to create predictive signatures for everyday clinical practice.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Article Biochemical Research Methods

Exosome detection via the ultrafast-isolation system: EXODUS

Yuchao Chen et al.

Summary: The study introduces an ultrafast isolation system called EXODUS for efficient purification of exosomes from biofluids, with superior speed, purity, and yield compared to other isolation techniques.

NATURE METHODS (2021)

Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Endocrinology & Metabolism

Pathophysiology of NASH in endocrine diseases

Karim Gariani et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the industrialized world, ranging from simple steatosis to hepatocellular injury and inflammation, commonly associated with type 2 diabetes and insulin resistance. NASH is also linked to various endocrine diseases.

ENDOCRINE CONNECTIONS (2021)

Review Biochemistry & Molecular Biology

Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact

David Hojland Ipsen et al.

Summary: NAFLD is a leading chronic liver disease globally, with a complex pathogenesis involving crosstalk between multiple cellular networks. Extracellular vesicles (EVs) have gained attention as mediators of cellular communication, potentially serving as disease markers and treatment targets in future NAFLD research.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

What can urinary exosomes tell us?

Rui Vitorino et al.

Summary: Exosomes play crucial roles in biochemical processes, organ system communication, and drug delivery, garnering significant attention in current biomedical research. This paper focuses on the significance of urinary exosomes in understanding disease pathophysiology, discussing isolation methods, novel biomarkers, and future trends in the field.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Review Endocrinology & Metabolism

Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease

Takefumi Kimura et al.

Summary: The prevalence of NAFLD is increasing globally, with controlling NASH events being a current medical need. Hepatic fibrosis is a key factor in NAFLD/NASH prognosis, highlighting the importance of understanding GPCRs and developing related therapies. GPCRs play a role in regulating liver function, and further research on their impact on hepatic fibrosis may lead to novel treatments for NAFLD/NASH.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Physiology

Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease

Jordan D. Secor et al.

Summary: Free fatty acid receptors (FFARs) play important roles in human physiology, particularly in liver health and disease, with implications in various disorders such as non-alcoholic fatty liver disease and diabetes.

FRONTIERS IN PHYSIOLOGY (2021)

Review Gastroenterology & Hepatology

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

Mojgan Masoodi et al.

Summary: Metabolomics and lipidomics approaches are utilized to identify biomarkers for NAFLD, with significant contributions in clinical studies; key metabolic pathway alterations in NAFLD and NASH have been identified, potentially serving as biomarkers for non-invasive diagnostic tests. Despite the discovery of potential biomarkers, few have been validated for clinical use.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Cell Biology

Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles

Uta Erdbrugger et al.

Summary: Urine is commonly used for clinical diagnosis and biomedical research, and the discovery of extracellular vesicles (EV) in urine has opened a new scientific field. However, methods for isolating and characterizing urinary extracellular vesicles (uEVs) need further optimization and standardization to advance scientific research and translation into clinical practice. Recommendations for improved rigor, reproducibility, and interoperability in uEV research are provided to address current challenges and gaps in the field.

JOURNAL OF EXTRACELLULAR VESICLES (2021)

Article Gastroenterology & Hepatology

Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1

Fangjie Jiang et al.

JOURNAL OF HEPATOLOGY (2020)

Review Biochemical Research Methods

Lipidomics from sample preparation to data analysis: a primer

Thomas Zuellig et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

Twenty years of metabonomics: so what has metabonomics done for toxicology?

Julian L. Griffin

XENOBIOTICA (2020)

Article Cardiac & Cardiovascular Systems

Metabolomics and Proteomics in Type 2 Diabetes

Zsu-Zsu Chen et al.

CIRCULATION RESEARCH (2020)

Review Endocrinology & Metabolism

Metabolic drivers of non-alcoholic fatty liver disease

Kendra K. Bence et al.

MOLECULAR METABOLISM (2020)

Review Biochemistry & Molecular Biology

Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants

Clemence Rives et al.

BIOMOLECULES (2020)

Review Medical Laboratory Technology

Advances in lipidomics

Henri F. Avela et al.

CLINICA CHIMICA ACTA (2020)

Review Gastroenterology & Hepatology

Lipidomics in non-alcoholic fatty liver disease

Sofia Kartsoli et al.

WORLD JOURNAL OF HEPATOLOGY (2020)

Review Spectroscopy

Metabolomics toward personalized medicine

Minnie Jacob et al.

MASS SPECTROMETRY REVIEWS (2019)

Article Gastroenterology & Hepatology

Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis

Keisuke Kakisaka et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Past, present and future perspectives in nonalcoholic fatty liver disease

Arun J. Sanyal

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise

Vincent Wai-Sun Wong et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Oncology

Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers

Tore Skotland et al.

EUROPEAN JOURNAL OF CANCER (2017)

Article Multidisciplinary Sciences

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients

Franck Chiappini et al.

SCIENTIFIC REPORTS (2017)

Review Oncology

Cancer exosomes in urine: a promising biomarker source

Isabella Panfoli

TRANSLATIONAL CANCER RESEARCH (2017)

Article Gastroenterology & Hepatology

Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes

Petra Hirsova et al.

GASTROENTEROLOGY (2016)

Article Clinical Neurology

Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease

Kyle B. Fraser et al.

MOVEMENT DISORDERS (2016)

Article Endocrinology & Metabolism

Effect of Extracellular Vesicles of Human Adipose Tissue on Insulin Signaling in Liver and Muscle Cells

Mariette E. G. Kranendonk et al.

OBESITY (2014)

Article Endocrinology & Metabolism

Plasma metabolomic profile in nonalcoholic fatty liver disease

Satish C. Kalhan et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2011)

Article Agriculture, Multidisciplinary

Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats

Bungo Shirouchi et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)